Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder
Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder At the beginning of the COVID-19 pandemic, federal agencies permitted telehealth initiation of buprenorphine treatment for opioid use disorder (OUD) without in-person assessment. This longitudinal cohort analysis found that a telehealth-only platform reduced risk of buprenorphine discontinuation compared [...]